Spots Global Cancer Trial Database for stage i colon cancer
Every month we try and update this database with for stage i colon cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer | NCT00274885 | Cancer | oxaliplatin management of t... | 18 Years - | National Cancer Institute (NCI) | |
| Biomarker-Guided Fluorouracil in Treating Patients With Colorectal Cancer Receiving Combination Chemotherapy | NCT01164215 | Colorectal Canc... Diarrhea Neutropenia | fluorouracil leucovorin oxaliplatin | - | UNC Lineberger Comprehensive Cancer Center | |
| Lymphatic Mapping and Sentinel Lymph Node Biopsy in the Treatment of Colorectal Cancer | NCT00005640 | Colorectal Canc... | Preoperative En... Technetium Tc 9... Gamma Probe Biopsy of Senti... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Fluorouracil and Oxaliplatin With or Without Panitumumab In Treating Patients With High-Risk Colon Cancer That Can Be Removed by Surgery | NCT00647530 | Colorectal Canc... | panitumumab capecitabine fluorouracil oxaliplatin | 18 Years - | University of Birmingham | |
| Genetic Study of Young Patients With Colorectal Cancer | NCT00044967 | Colorectal Canc... | microsatellite ... | 18 Years - 49 Years | Alliance for Clinical Trials in Oncology | |
| Genetic Study of Patients and Families With a History of Colorectal Cancer | NCT00003648 | Colorectal Canc... | DNA stability a... gene rearrangem... | - | Alliance for Clinical Trials in Oncology | |
| Lymphatic Mapping, Sentinel Lymph Node Analysis, and Blood Tests in Detecting and Predicting Early Micrometastases in Patients With Colorectal Cancer | NCT00625625 | Colorectal Canc... | isosulfan blue polymerase chai... diagnostic labo... immunohistochem... diagnostic lymp... therapeutic con... therapeutic lym... | 18 Years - | National Cancer Institute (NCI) | |
| Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery | NCT00004895 | Colorectal Canc... Constipation, I... Extrahepatic Bi... Gastric Cancer Gastrointestina... Nausea and Vomi... Ovarian Cancer Pancreatic Canc... Peritoneal Cavi... Small Intestine... | octreotide acet... | 18 Years - | Northwestern University | |
| Celecoxib in Preventing Polyps in Patients Who Have Undergone Surgery for Stage I Colon Cancer | NCT00087256 | Colorectal Canc... | Celecoxib placebo | 18 Years - | NSABP Foundation Inc | |
| Resveratrol in Treating Patients With Colorectal Cancer That Can Be Removed By Surgery | NCT00433576 | Adenocarcinoma ... Adenocarcinoma ... Stage I Colon C... Stage I Rectal ... Stage II Colon ... Stage II Rectal... Stage III Colon... Stage III Recta... | resveratrol pharmacological... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Differences in Timely Cancer Diagnosis in African American and Caucasian Patients With Newly Diagnosed Colorectal Cancer | NCT00856115 | Colorectal Canc... | medical chart r... questionnaire a... study of socioe... survey administ... | 21 Years - | Case Comprehensive Cancer Center | |
| Follow-Up Study of Patients Who Have Undergone Surgery for Stage I, Stage II, or Stage III Colorectal Cancer | NCT00560365 | Colorectal Canc... | laboratory biom... computed tomogr... magnetic resona... quality-of-life... | 50 Years - | National Cancer Institute (NCI) | |
| Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer | NCT00897793 | Breast Cancer Colorectal Canc... Head and Neck C... Lung Cancer Prostate Cancer | venipuncture radiation thera... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| Laparoscopic-Assisted Surgery Compared With Open Surgery in Treating Patients With Colon Cancer | NCT00002575 | Colorectal Canc... | conventional su... laparoscopic su... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Genetic Study of Familial Factors in Patients With Colon Cancer | NCT00055848 | Colorectal Canc... | cytogenetic ana... gene mapping microarray anal... | - 70 Years | Alliance for Clinical Trials in Oncology | |
| Lymphatic Mapping, Sentinel Lymph Node Analysis, and Blood Tests in Detecting and Predicting Early Micrometastases in Patients With Colorectal Cancer | NCT00625625 | Colorectal Canc... | isosulfan blue polymerase chai... diagnostic labo... immunohistochem... diagnostic lymp... therapeutic con... therapeutic lym... | 18 Years - | National Cancer Institute (NCI) | |
| Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer | NCT00436410 | Adrenocortical ... Breast Cancer Colorectal Canc... Gastrointestina... Kidney Cancer Liver Cancer Melanoma (Skin) Ovarian Cancer Pancreatic Canc... Sarcoma | colloidal gold-... electron micros... pharmacological... conventional su... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder | NCT00489515 | Colorectal Canc... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine... | 18 Years - 120 Years | Wake Forest University Health Sciences | ||
| Biomarker-Guided Fluorouracil in Treating Patients With Colorectal Cancer Receiving Combination Chemotherapy | NCT01164215 | Colorectal Canc... Diarrhea Neutropenia | fluorouracil leucovorin oxaliplatin | - | UNC Lineberger Comprehensive Cancer Center | |
| Eniluracil and Surgery in Treating Patients With Primary or Metastatic Colorectal Cancer | NCT00004195 | Colorectal Canc... | eniluracil conventional co... | 19 Years - 80 Years | University of Alabama at Birmingham | |
| Memantine Hydrochloride in Helping Cancer Survivors Stop Smoking | NCT01535040 | Breast Cancer Colorectal Canc... Lung Cancer Prostate Cancer Tobacco Use Dis... | memantine hydro... placebo | 18 Years - | Wake Forest University Health Sciences | |
| Study of Micrometastases in Patients With Stage I or Stage II Localized Colon Cancer That Can Be Removed by Surgery | NCT01097265 | Colorectal Canc... | capecitabine oxaliplatin active surveill... laboratory biom... adjuvant therap... lymph node mapp... sentinel lymph ... | 18 Years - | National Cancer Institute (NCI) | |
| Lymphatic Mapping, Sentinel Lymph Node Analysis, and Blood Tests in Detecting and Predicting Early Micrometastases in Patients With Colorectal Cancer | NCT00625625 | Colorectal Canc... | isosulfan blue polymerase chai... diagnostic labo... immunohistochem... diagnostic lymp... therapeutic con... therapeutic lym... | 18 Years - | National Cancer Institute (NCI) | |
| Fluorouracil and Oxaliplatin With or Without Panitumumab In Treating Patients With High-Risk Colon Cancer That Can Be Removed by Surgery | NCT00647530 | Colorectal Canc... | panitumumab capecitabine fluorouracil oxaliplatin | 18 Years - | University of Birmingham | |
| EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer | NCT00087191 | Advanced Adult ... Carcinoma of th... Fallopian Tube ... Gastrointestina... Localized Extra... Localized Gallb... Localized Gastr... Localized Resec... Localized Unres... Metastatic Gast... Ovarian Sarcoma Ovarian Stromal... Primary Periton... Recurrent Adult... Recurrent Adult... Recurrent Colon... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Recta... Recurrent Small... Recurrent Uteri... Regional Gastro... Small Intestine... Small Intestine... Small Intestine... Stage 0 Non-sma... Stage I Adult S... Stage I Colon C... Stage I Gastric... Stage I Non-sma... Stage I Ovarian... Stage I Ovarian... Stage I Pancrea... Stage I Rectal ... Stage I Uterine... Stage II Adult ... Stage II Colon ... Stage II Gastri... Stage II Non-sm... Stage II Ovaria... Stage II Ovaria... Stage II Pancre... Stage II Rectal... Stage II Uterin... Stage III Adult... Stage III Colon... Stage III Gastr... Stage III Ovari... Stage III Ovari... Stage III Pancr... Stage III Recta... Stage III Uteri... Stage IIIA Non-... Stage IIIB Non-... Stage IV Adult ... Stage IV Colon ... Stage IV Gastri... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Rectal... Stage IV Uterin... Unresectable Ex... Unresectable Ga... | EF5 motexafin lutet... pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Single Incision Laparoscopic Surgery in Treating Patients With Colorectal Disease | NCT01656746 | Adenomatous Pol... Crohn Disease Familial Adenom... Hereditary Inte... Recurrent Colon... Stage I Colon C... Stage IIA Colon... Stage IIB Colon... Stage IIC Colon... Stage IIIA Colo... Stage IIIB Colo... Stage IIIC Colo... | therapeutic lap... | 18 Years - 80 Years | Ohio State University Comprehensive Cancer Center | |
| Pain and Fatigue Management in Patients With Breast Cancer, Prostate Cancer, Colon Cancer, or Lung Cancer | NCT00900835 | Breast Cancer Colorectal Canc... Fatigue Lung Cancer Pain Prostate Cancer | educational int... questionnaire a... study of socioe... assessment of t... fatigue assessm... quality-of-life... standard follow... | 18 Years - | City of Hope Medical Center | |
| Survivorship Care Planning in Patients With Colorectal or Non-Small Cell Lung Cancer | NCT01741636 | Stage I Colon C... Stage I Rectal ... Stage IA Non-sm... Stage IB Non-sm... Stage IIA Colon... Stage IIA Non-s... Stage IIA Recta... Stage IIB Colon... Stage IIB Non-s... Stage IIB Recta... Stage IIC Colon... Stage IIC Recta... Stage IIIA Colo... Stage IIIA Non-... Stage IIIA Rect... Stage IIIB Colo... Stage IIIB Non-... Stage IIIB Rect... Stage IIIC Colo... Stage IIIC Rect... | educational int... questionnaire a... quality-of-life... | 21 Years - | City of Hope Medical Center | |
| Fluorouracil and Oxaliplatin With or Without Panitumumab In Treating Patients With High-Risk Colon Cancer That Can Be Removed by Surgery | NCT00647530 | Colorectal Canc... | panitumumab capecitabine fluorouracil oxaliplatin | 18 Years - | University of Birmingham | |
| Conventional Surgery Compared With Laparoscopic-Assisted Surgery in Treating Patients With Colorectal Cancer | NCT00003354 | Colorectal Canc... | conventional su... laparoscopic su... | 18 Years - | National Cancer Institute (NCI) | |
| Diagnostic Procedure for Identifying Patients With Metastatic Colorectal Cancer | NCT00003186 | Colorectal Canc... Metastatic Canc... | isosulfan blue lymphangiograph... sentinel lymph ... | 18 Years - 75 Years | Roswell Park Cancer Institute | |
| Conventional Surgery Compared With Laparoscopic-Assisted Surgery in Treating Patients With Colorectal Cancer | NCT00003354 | Colorectal Canc... | conventional su... laparoscopic su... | 18 Years - | National Cancer Institute (NCI) | |
| Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen | NCT00016380 | Cancer | dexamethasone ondansetron quality-of-life... | 16 Years - 120 Years | Canadian Cancer Trials Group | |
| Survivorship Care Planning in Patients With Colorectal or Non-Small Cell Lung Cancer | NCT01741636 | Stage I Colon C... Stage I Rectal ... Stage IA Non-sm... Stage IB Non-sm... Stage IIA Colon... Stage IIA Non-s... Stage IIA Recta... Stage IIB Colon... Stage IIB Non-s... Stage IIB Recta... Stage IIC Colon... Stage IIC Recta... Stage IIIA Colo... Stage IIIA Non-... Stage IIIA Rect... Stage IIIB Colo... Stage IIIB Non-... Stage IIIB Rect... Stage IIIC Colo... Stage IIIC Rect... | educational int... questionnaire a... quality-of-life... | 21 Years - | City of Hope Medical Center | |
| Immunoscintigraphy Using Radiolabeled Monoclonal Antibody in Finding Tumor Cells in Patients With Colorectal Cancer | NCT00647153 | Colorectal Canc... | pharmacological... single photon e... iodine I 123 an... | 18 Years - 120 Years | City of Hope Medical Center | |
| Lymphatic Mapping and Sentinel Lymph Node Biopsy in the Treatment of Colorectal Cancer | NCT00005640 | Colorectal Canc... | Preoperative En... Technetium Tc 9... Gamma Probe Biopsy of Senti... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery | NCT00004895 | Colorectal Canc... Constipation, I... Extrahepatic Bi... Gastric Cancer Gastrointestina... Nausea and Vomi... Ovarian Cancer Pancreatic Canc... Peritoneal Cavi... Small Intestine... | octreotide acet... | 18 Years - | Northwestern University | |
| Family Quality of Life Among Families With a Member Who is a Cancer Patient | NCT00544336 | Breast Cancer Colorectal Canc... Head and Neck C... Lung Cancer Prostate Cancer Solid Tumor | questionnaire a... survey administ... quality-of-life... | 21 Years - | Vanderbilt-Ingram Cancer Center | |
| Studying a Quality of Life Questionnaire in Patients With Colorectal Cancer | NCT00564694 | Colorectal Canc... | psychosocial as... quality-of-life... | 18 Years - | National Cancer Institute (NCI) | |
| S1013: Validation of Cancer Questionnaire for Skin Toxicities in Patients With Colorectal Cancer or Lung Cancer Receiving Cetuximab, Panitumumab, or Erlotinib Hydrochloride | NCT01416688 | Colorectal Canc... Dermatologic Co... Lung Cancer Therapy-related... | assessment of t... psychosocial as... quality-of-life... | 18 Years - 120 Years | SWOG Cancer Research Network | |
| Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor | NCT01096381 | Breast Cancer Cardiovascular ... Colorectal Canc... Fallopian Tube ... Head and Neck C... Lung Cancer Ovarian Cancer Peritoneal Cavi... Unspecified Adu... | laboratory biom... questionnaire a... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor | NCT01096381 | Breast Cancer Cardiovascular ... Colorectal Canc... Fallopian Tube ... Head and Neck C... Lung Cancer Ovarian Cancer Peritoneal Cavi... Unspecified Adu... | laboratory biom... questionnaire a... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer | NCT00003329 | Breast Cancer Colorectal Canc... Lung Cancer Prostate Cancer | gene mapping | 0 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Exercise and Dietary Counseling in Improving Physical Activity, Nutrition, and Quality of Life in Older Long-Term Cancer Survivors Who Are Overweight | NCT00303875 | Breast Cancer Colorectal Canc... Prostate Cancer | behavioral diet... | 65 Years - 120 Years | Duke University | |
| Lymphatic Mapping and Sentinel Lymph Node Biopsy in the Treatment of Colorectal Cancer | NCT00005640 | Colorectal Canc... | Preoperative En... Technetium Tc 9... Gamma Probe Biopsy of Senti... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer | NCT00003329 | Breast Cancer Colorectal Canc... Lung Cancer Prostate Cancer | gene mapping | 0 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest Cancer | NCT00372840 | Breast Cancer Colorectal Canc... Lung Cancer Malignant Mesot... Prostate Cancer Psychosocial Ef... Thymoma and Thy... | educational int... psychosocial as... quality-of-life... | 18 Years - 120 Years | Fox Chase Cancer Center | |
| Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving Oxaliplatin | NCT00884767 | Chemotherapeuti... Colorectal Canc... Neurotoxicity | FOLFOX regimen fluorouracil leucovorin calc... oxaliplatin gene expression... protein express... proteomic profi... laboratory biom... pharmacogenomic... | 18 Years - | National Cancer Institute (NCI) | |
| Study of Biomarkers in Blood & Tissue Samples From Patients With Colorectal Cancer or Polyps & Patients Without Polyps | NCT00898378 | Colorectal Canc... Healthy, no Evi... Precancerous Co... | gene expression... polymerase chai... polymorphism an... protein express... proteomic profi... gas chromatogra... laboratory biom... liquid chromato... mass spectromet... questionnaire a... | 18 Years - | Indiana University | |
| Cholecalciferol(25-[OH]-Vitamin D) in Treating Patients With Colorectal Cancer | NCT01403103 | Mucinous Adenoc... Mucinous Adenoc... Signet Ring Ade... Signet Ring Ade... Stage I Colon C... Stage I Rectal ... | cholecalciferol biopsy protein express... enzyme-linked i... laboratory biom... reverse transcr... | 18 Years - | Case Comprehensive Cancer Center | |
| Cholecalciferol(25-[OH]-Vitamin D) in Treating Patients With Colorectal Cancer | NCT01403103 | Mucinous Adenoc... Mucinous Adenoc... Signet Ring Ade... Signet Ring Ade... Stage I Colon C... Stage I Rectal ... | cholecalciferol biopsy protein express... enzyme-linked i... laboratory biom... reverse transcr... | 18 Years - | Case Comprehensive Cancer Center | |
| Erlotinib Hydrochloride in Treating Patients With Stage I-III Colorectal Cancer or Adenoma | NCT00754494 | Adenomatous Pol... Recurrent Colon... Recurrent Recta... Stage I Colon C... Stage I Rectal ... Stage IIA Colon... Stage IIA Recta... Stage IIB Colon... Stage IIB Recta... Stage IIC Colon... Stage IIC Recta... Stage IIIA Colo... Stage IIIA Rect... Stage IIIB Colo... Stage IIIB Rect... Stage IIIC Colo... Stage IIIC Rect... | erlotinib hydro... placebo laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Eniluracil and Surgery in Treating Patients With Primary or Metastatic Colorectal Cancer | NCT00004195 | Colorectal Canc... | eniluracil conventional co... | 19 Years - 80 Years | University of Alabama at Birmingham | |
| Oxaliplatin Plus Capecitabine in Treating Patients With Colorectal, Appendix, or Small Bowel Cancer | NCT00019773 | Carcinoma of th... Colorectal Canc... Small Intestine... | capecitabine oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| Memantine Hydrochloride in Helping Cancer Survivors Stop Smoking | NCT01535040 | Breast Cancer Colorectal Canc... Lung Cancer Prostate Cancer Tobacco Use Dis... | memantine hydro... placebo | 18 Years - | Wake Forest University Health Sciences | |
| Cholecalciferol and Calcium Carbonate in Treating Patients With Colon Cancer That Has Been Removed by Surgery | NCT00470353 | Colorectal Canc... | calcium carbona... cholecalciferol immunohistochem... laboratory biom... pharmacological... biopsy | 18 Years - 120 Years | Roswell Park Cancer Institute | |
| Laparoscopic-Assisted Surgery Compared With Open Surgery in Treating Patients With Colon Cancer | NCT00002575 | Colorectal Canc... | conventional su... laparoscopic su... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery | NCT01011478 | Colorectal Canc... Precancerous Co... | rosuvastatin placebo | 18 Years - | NSABP Foundation Inc | |
| Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest Cancer | NCT00372840 | Breast Cancer Colorectal Canc... Lung Cancer Malignant Mesot... Prostate Cancer Psychosocial Ef... Thymoma and Thy... | educational int... psychosocial as... quality-of-life... | 18 Years - 120 Years | Fox Chase Cancer Center | |
| Positron Emission Tomography/Computed Tomography Scanning Before Surgery in Patients With Non-Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer, Esophageal Cancer, or Head and Neck Cancer | NCT01254591 | Breast Cancer Colorectal Canc... Esophageal Canc... Head and Neck C... Lung Cancer | 18F-fluoromison... fluorescence an... laboratory biom... infrared thermo... magnetic resona... therapeutic con... [18F]-ML-10 fludeoxyglucose... rubidium Rb-82 | - | National Cancer Institute (NCI) | |
| Diagnostic Procedure for Identifying Patients With Metastatic Colorectal Cancer | NCT00003186 | Colorectal Canc... Metastatic Canc... | isosulfan blue lymphangiograph... sentinel lymph ... | 18 Years - 75 Years | Roswell Park Cancer Institute | |
| Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen | NCT00016380 | Cancer | dexamethasone ondansetron quality-of-life... | 16 Years - 120 Years | Canadian Cancer Trials Group | |
| Health Behaviors in Patients Who Have Finished Treatment for Stage I, Stage II, or Stage III Colorectal Cancer | NCT00966667 | Colorectal Canc... | 21 Years - | Rutgers, The State University of New Jersey | ||
| Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer | NCT00003329 | Breast Cancer Colorectal Canc... Lung Cancer Prostate Cancer | gene mapping | 0 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving Oxaliplatin | NCT00884767 | Chemotherapeuti... Colorectal Canc... Neurotoxicity | FOLFOX regimen fluorouracil leucovorin calc... oxaliplatin gene expression... protein express... proteomic profi... laboratory biom... pharmacogenomic... | 18 Years - | National Cancer Institute (NCI) | |
| Comparison of Sulindac, Aspirin, and Ursodiol in Preventing Colorectal Cancer | NCT00062023 | Colorectal Canc... | Acetylsalicylic... Sulindac Ursodiol Sulindac Placeb... | 40 Years - 80 Years | M.D. Anderson Cancer Center | |
| UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With Cancer | NCT00900094 | Breast Cancer Colorectal Canc... Esophageal Canc... Liver Cancer Lung Cancer Ovarian Cancer Pancreatic Canc... | fluorescence in... polymerase chai... protein express... immunohistochem... laboratory biom... mass spectromet... | 18 Years - | University of Michigan Rogel Cancer Center | |
| Memantine Hydrochloride in Helping Cancer Survivors Stop Smoking | NCT01535040 | Breast Cancer Colorectal Canc... Lung Cancer Prostate Cancer Tobacco Use Dis... | memantine hydro... placebo | 18 Years - | Wake Forest University Health Sciences | |
| Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel Obstruction | NCT00004911 | Colorectal Canc... Constipation, I... Gastric Cancer Gastrointestina... Gastrointestina... Quality of Life Small Intestine... | bowel obstructi... quality-of-life... | 18 Years - | Northwestern University | |
| Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction | NCT00004910 | Colorectal Canc... Constipation, I... Extrahepatic Bi... Gastric Cancer Gastrointestina... Gastrointestina... Pancreatic Canc... Quality of Life Small Intestine... | bowel obstructi... quality-of-life... | 18 Years - | Northwestern University | |
| Pain and Fatigue Management in Patients With Breast Cancer, Prostate Cancer, Colon Cancer, or Lung Cancer | NCT00900835 | Breast Cancer Colorectal Canc... Fatigue Lung Cancer Pain Prostate Cancer | educational int... questionnaire a... study of socioe... assessment of t... fatigue assessm... quality-of-life... standard follow... | 18 Years - | City of Hope Medical Center | |
| Genetic Study of Young Patients With Colorectal Cancer | NCT00044967 | Colorectal Canc... | microsatellite ... | 18 Years - 49 Years | Alliance for Clinical Trials in Oncology | |
| Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor | NCT01096381 | Breast Cancer Cardiovascular ... Colorectal Canc... Fallopian Tube ... Head and Neck C... Lung Cancer Ovarian Cancer Peritoneal Cavi... Unspecified Adu... | laboratory biom... questionnaire a... | 18 Years - | Vanderbilt-Ingram Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
